Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jul 15;38(15):2151–2161. doi: 10.1089/neu.2021.0012

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Lucie Bourguignon et al., 2021; Published by Mary Ann Liebert, Inc.

This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (CC-BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.

PMC Copyright notice

Fig. 1. — Natural progression of the complete blood count in patients with spinal cord injury who were enrolled in the Sygen trial. Three different patterns of progression were observed. First, the blood markers, such as thrombocytes, remained constant and within the range of able-bodied people. Second, blood markers were pathological immediately after the trauma, but recovered over the course of a year and reached the normal range. Erythrocytes, hemoglobin, and leucocytes are characterized by such a course. Third, values were initially within the normal range, but as a function of time they became pathological when compared with those of able-bodied people. Hematocrit is one such example (not shown here). For clinical decision making as well as the design and implementation of clinical trials, it is of utmost importance to know the temporal progression of these blood markers. For further exploration of the data, please refer to the web application Haemosurveillance (https://jutzelec.shinyapps.io/Haemosurveillance/).